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Abstract. Cancer is a deadly disease evading all human efforts to understand its etiology, 
prevention and cure. In the cancer, chronicmyelogenous leukemia is one type. It is also known as chronic 
myeloid leukemia. It is a malignant cancer of the myeloid line of cells in the bone marrow that results in 
the uncontrolled growth of white blood cells in the bone marrow, bloodstream, and body tissues. The 
colorectal cancer is another type of cancer that occurs in the colon or rectum. Sometimes it is called colon 
cancer. Management of these cancers is highly difficult. In persuation of our goal to synthesise cancer 
active compounds, the author accomplished synthesis of substituted amino methylene bisphosphonates 
(3a-j) and studied their antitumor activity. 
 
 
  
